Last reviewed · How we verify
NCT05067816
Med-South Lifestyle Program Implementation Study
NA trial testing Med-South Lifestyle Program in Healthy Lifestyle in 368 participants. Completed in 1 February 2024.
29 September 2023
Quick facts
| Lead sponsor | University of North Carolina, Chapel Hill |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 368 |
| Start date | 26 October 2021 |
| Primary completion | 29 September 2023 |
| Estimated completion | 1 February 2024 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Med-South Lifestyle Program
Conditions studied
- Healthy Lifestyle — all drugs for Healthy Lifestyle →
Sponsor
University of North Carolina, Chapel Hill
Who can join
Adults 18 to 80, any sex, with Healthy Lifestyle. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine the processes by which a previously proven lifestyle intervention (the Med-South Lifestyle Program) can most effectively and efficiently be translated into public health and clinical practice to positively impact chronic disease risk reduction among mostly minority, rural, and medically underserved populations.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Scaling up the Med-South Lifestyle Program in public health settings to reduce chronic disease risk: a hybrid implementation-effectiveness study.
Samuel-Hodge CD, Pham L, Lyons K, Draeger LB, et al · · 2025 · cited 1× · PMID 40538692 · DOI 10.3389/fpubh.2025.1564567
Verify or expand the search:
- PubMed search for NCT05067816
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Med-South Lifestyle Program
Trials testing the same drug.
- NCT04421703 — Med-South Lifestyle Study: Phase 1 · NA · completed
Other recruiting trials for Healthy Lifestyle
Currently open trials in the same condition.
- NCT07480174 — Effects of Tai Chi and Yoga on Flexibility, Anxiety, and Sleep Quality in Women · NA · recruiting
- NCT07441655 — Families Implementing Good Health Traditions for Life · NA · recruiting
- NCT07490821 — Effects of Physical Activity Training on Physical Fitness and Quality of Life in Paramedic Students · NA · active not recruiting
- NCT06731452 — Exploring Neurophysiological Markers of Brain Health · NA · recruiting
- NCT06901037 — A Pilot Randomized Controlled Trial of Chatbot Use in Older Adults for Lifestyle Change · NA · recruiting
Other University of North Carolina, Chapel Hill trials
Trials by the same sponsor.
- NCT06841913 — Woodsmoke Exposure, Influenza Infection, and Nasal Immunity · Phase 4 · suspended
- NCT07383428 — The INICIO-Guatemala Study · NA · not yet recruiting
- NCT07528443 — Ultraprocessed Foods in Colombia · NA · not yet recruiting
- NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
- NCT07534254 — Piloting a Generative Artificial Intelligence Chatbot in a Mobile Weight Loss Program · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05067816 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of North Carolina, Chapel Hill
- Last refreshed: 10 October 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05067816.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing